Genesis Cabrera
Family · New York, NYNPI 1255063343
Payments from drug & device makers
Across 278 payments — averaging $29.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sanofi$1K
- Lilly USA, LLC$1K
- Genentech USA, Inc.$750
- Johnson & Johnson$740
- Arcutis Biotherapeutics, Inc.$441
- plus $2K from 14 others
What the payments were for
- Consulting fees$7509%
- Food & beverage$7,33089%
- Education$1822%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $1,471 |
| Sanofi | 42 | $1,432 |
| Lilly USA, LLC | 50 | $1,086 |
| Genentech USA, Inc. | 1 | $750 |
| Johnson & Johnson | 28 | $740 |
| Arcutis Biotherapeutics, Inc. | 16 | $441 |
| E.r. Squibb & Sons, L.L.C. | 8 | $357 |
| LEO Pharma Inc. | 21 | $351 |
| Incyte Corporation | 7 | $261 |
| Regeneron Healthcare Solutions, Inc. | 7 | $259 |
| Pfizer | 11 | $229 |
| UCB, Inc. | 6 | $202 |
| Galderma Laboratories, L.p. | 8 | $195 |
| Sun Pharmaceutical Industries Inc. | 7 | $171 |
| Sanofi-aventis U.S. LLC | 1 | $87 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $83 |
| Dermavant Sciences, Inc. | 3 | $61 |
| Biofrontera Inc. | 2 | $46 |
| Organon | 1 | $22 |
| Novartis | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,262 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bimzelx AutoinjectorBimekizumab-Bkzx | 19 | $261,432 |
| Taltz AutoinjectorIxekizumab | 27 | $176,989 |
| Dupixent PenDupilumab | 44 | $167,741 |
| Dupixent SyringeDupilumab | 35 | $129,665 |
Paid to pharmacies, not to this prescriber.
Other family in New York
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Mary Sullivan-WhalenNew York$137K
- Leslie WoronaNew York$77K
- Thomas SaglimbeniNew York$48K
- Kathryn JohnsonNew York$48K
- Derek PinedaNew York$38K
- Rebecca SchoriNew York$32K
- Evangelia NezisNew York$22K
- Colette NelsonNew York$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.